tiprankstipranks
Trending News
More News >
Protara Therapeutics (TARA)
NASDAQ:TARA
US Market

Protara Therapeutics (TARA) Income Statement

Compare
1,261 Followers

Protara Therapeutics Income Statement

Last quarter (Q3 2025), Protara Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Protara Therapeutics's net income was $-13.26M. See Protara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -341.00K$ 0.00$ 0.00$ -196.00K
Operating Expenses
$ 49.15M$ 43.27M$ 67.06M$ 47.49M$ 34.25M
Depreciation and Amortization
$ 332.00K$ 341.00K$ 248.00K$ 117.00K$ 196.00K
EBITDA
$ -48.82M$ -43.27M$ -64.57M$ -45.40M$ -33.78M
Operating Income
$ -49.15M$ -43.61M$ -67.06M$ -47.49M$ -34.44M
Other Income/Expenses
$ 4.56M$ 3.19M$ 1.11M$ 237.00K$ 466.00K
Pretax Income
$ -44.60M$ -40.42M$ -65.95M$ -47.25M$ -33.98M
Net Income
$ -44.60M$ -40.42M$ -65.95M$ -47.25M$ -33.98M
Per Share Metrics
Basic EPS
$ -2.17$ -3.57$ -5.86$ -4.20$ -4.70
Diluted EPS
$ -2.17$ -3.57$ -5.86$ -4.20$ -4.70
Weighted Average Shares Outstanding
20.59M 11.33M 11.26M 11.23M 7.23M
Weighted Average Shares Outstanding (Diluted)
20.59M 11.33M 11.26M 11.23M 7.23M
Currency in USD

Protara Therapeutics Earnings and Revenue History